Vaccine companies are making bivalent (with Wuhan) even though Wuhan is no longer a problem.
When boosting with new monovalent Omicron jabs immune imprint is clear. Munch more Wuhan antibodies are created then the one in the jab.
Vaccine companies are making bivalent (with Wuhan) even though Wuhan is no longer a problem.
When boosting with new monovalent Omicron jabs immune imprint is clear. Munch more Wuhan antibodies are created then the one in the jab.
No replies yet.